Viral Excretion Among COVID-19 Omicron Recurrence Patients

Sponsor
RenJi Hospital (Other)
Overall Status
Recruiting
CT.gov ID
NCT05470426
Collaborator
(none)
35
1
13
2.7

Study Details

Study Description

Brief Summary

The study analyzes the viral nucleic acid excretion and its influencing factors of SARS-COV-2 Omicron recurrence patients.

Condition or Disease Intervention/Treatment Phase
  • Other: COVID-19 Omicron Recurrence

Study Design

Study Type:
Observational
Anticipated Enrollment :
35 participants
Observational Model:
Cohort
Time Perspective:
Prospective
Official Title:
Viral Excretion and Its Influencing Factors Among COVID-19 Omicron Recurrence Patients
Anticipated Study Start Date :
Jul 1, 2022
Anticipated Primary Completion Date :
Jul 1, 2023
Anticipated Study Completion Date :
Aug 1, 2023

Outcome Measures

Primary Outcome Measures

  1. COVID-19 Omicron Recurrence [Six months]

    COVID-19 Omicron Recurrence

Eligibility Criteria

Criteria

Ages Eligible for Study:
N/A and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Patients with nucleic acid detection N gene and ORF gene Ct value < 40 after discharge from hospital

  • Being able to provide basic information, living habits, vaccination information, admission information

Exclusion Criteria:
  • Single gene target positive

  • Patients with incomplete baseline data

Contacts and Locations

Locations

Site City State Country Postal Code
1 Renji Hospital Shanghai China 200123

Sponsors and Collaborators

  • RenJi Hospital

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
RenJi Hospital
ClinicalTrials.gov Identifier:
NCT05470426
Other Study ID Numbers:
  • IIT-2022-0102
First Posted:
Jul 22, 2022
Last Update Posted:
Jul 22, 2022
Last Verified:
Jul 1, 2022
Individual Participant Data (IPD) Sharing Statement:
Undecided
Plan to Share IPD:
Undecided
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jul 22, 2022